or Try an Advanced Search...

    Technical Analysis for BBLG - Bone Biologics Corp

    Grade Last Price % Change Price Change
    F 1.20 -1.64% -0.02
    BBLG closed down 1.64 percent on Monday, July 1, 2024, on 17 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical BBLG trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Shooting Star Candlestick Bearish -1.64%
    180 Bearish Setup Bearish Swing Setup -1.64%
    Calm After Storm Range Contraction -1.64%
    Doji - Bearish? Reversal -1.64%
    Wide Bands Range Expansion -1.64%
    Oversold Stochastic Weakness -1.64%
    Older End-of-Day Signals for BBLG ...

       Recent Intraday Alerts

    Alert Time
    Up 3% about 9 hours ago
    Down 1% about 9 hours ago
    Up 2% about 9 hours ago
    Up 1% about 9 hours ago
    60 Minute Opening Range Breakout 3 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    BBLG Chart by TradingView
    Basic chart:

    Profile

    Bone Biologics Corp Description

    Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. Its NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The company is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. Its platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

    Classification
    Sector: Healthcare
    Industry: Medical Devices
    Keywords: Biopharmaceutical Clinical Medicine Surgery Neurosurgery Platform Technology Orthopedic Surgery Sports Medicine Surgical Specialties Spinal Fusion Degenerative Disc Disease Spinal Fusion Applications

    Is BBLG a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 20 First patients treated in Bone Biologics spinal fusion trial
    Jun 20 First Two Patients Treated in Pilot Clinical Study with Bone Biologics’ NB1 Bone Graft Device in Spine Fusion
    Jun 20 BBLG Marks Important Milestone
    Jun 18 Life Sciences Virtual Investor Forum Agenda Announced for June 20th
    Jun 17 Bone Biologics Executives to be Interviewed in a “CEO Chat” by Zacks Small-Cap Research Analyst on June 20th
    May 16 BBLG Continues Progress as Testing Proceeds
    Mar 6 Bone Biologics Announces Closing of $2.0 Million Public Offering
    Mar 4 Bone Biologics rises 5% on $2M equity offering
    Mar 4 Bone Biologics Announces Pricing of $2.0 Million Public Offering
    Mar 1 Bone Biologics stock jumps after reporting progress with NB1 clinical program
    See more BBLG news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 14.16
    52 Week Low 1.13
    Average Volume 92,897
    200-Day Moving Average 3.17
    50-Day Moving Average 1.60
    20-Day Moving Average 1.41
    10-Day Moving Average 1.28
    Average True Range 0.18
    RSI (14) 33.33
    ADX 12.35
    +DI 20.25
    -DI 20.67
    Chandelier Exit (Long, 3 ATRs) 1.32
    Chandelier Exit (Short, 3 ATRs) 1.67
    Upper Bollinger Bands 1.73
    Lower Bollinger Band 1.08
    Percent B (%b) 0.18
    BandWidth 45.79
    MACD Line -0.13
    MACD Signal Line -0.12
    MACD Histogram -0.0138
    Fundamentals Value
    Market Cap 641.09 Thousand
    Num Shares 534 Thousand
    EPS -13.52
    Price-to-Earnings (P/E) Ratio -0.09
    Price-to-Sales 0.00
    Price-to-Book 0.44
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.29
    Resistance 3 (R3) 1.30 1.28 1.28
    Resistance 2 (R2) 1.28 1.26 1.28 1.27
    Resistance 1 (R1) 1.24 1.24 1.23 1.23 1.26
    Pivot Point 1.22 1.22 1.22 1.22 1.22
    Support 1 (S1) 1.18 1.20 1.17 1.17 1.14
    Support 2 (S2) 1.16 1.18 1.16 1.13
    Support 3 (S3) 1.12 1.16 1.13
    Support 4 (S4) 1.11